Advertisement

Pathologie pp 141-176 | Cite as

Lymphatische Neoplasien und ihre Manifestation im Knochenmark

  • Hans H. KreipeEmail author
Chapter

Zusammenfassung

Vorläuferzell-Lymphome und Leukämien der B- und T-Zellen, die akuten B- und T-lymphoblastischen Leukämien, betreffen häufig das Knochenmark. Die weitere Differenzierung erfordert kombinierte phänotypische und molekulare Analysen, die nach aktuellem Kenntnisstand hier behandelt werden. Reifzellige Lymphome betreffen das Knochenmark zumeist sekundär. Ein kleinerer Teil der Lymphome nimmt von hier seinen Ausgang (z.B. lymphoplasmozytisches Lymphom), bildet umschriebene Tumoren aus (sog. primäre Knochenlymphome) oder ist auf Knochenmark und Milz beschränkt (Haarzellleukämie, splenisches Lymphom). Das Infiltrationsmuster m Knochenmark neben der immunhistochemischen Charakterisierung ist für die verschiedenen Lymphomtypen charakteristisch. In diesem Kapitel werden damit umfassende und aktuelle Kenntnisse und Strategien für die Diagnostik und Differentialdiagnostik lymphatischer Knochenmarksinfiltrate vermittelt, die an der Praxis orientiert sind und sowohl in der Primärdiagnose eines Lymphoms, als auch für Staging, Risikostratifikation und Therapie Bedeutung haben.

Literatur

  1. 1.
    Aifantis I, Raetz E, Buonamici S (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8:380–390PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Alencar A, Pitcher D, Byrne G, Lossos IS (2010) Primary bone lymphoma – the University of Miami experience. Leuk Lymphoma 51:39–49PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405CrossRefGoogle Scholar
  4. 4.
    Arber DA, George TI (2005) Bone marrow biopsy involvement by non-Hodgkin’s lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 29:1549–1557PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ (2009) VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood 114:4687–4695PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Audouin J, Le Tourneau A, Molina T, Camilleri-Broët S, Adida C, Comperat E, Benattar L, Delmer A, Devidas A, Rio B, Diebold J (2003) Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol 122:404–412PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Baar J, Burkes RL, Gospodarowicz M (1999) Primary non-Hodgkin’s lymphoma of bone. Semin Oncol 26:270–275PubMedPubMedCentralGoogle Scholar
  8. 8.
    Bakshi NA, Ross CW, Finn WG, Valdez R, Ruiz R, Koujok K, Schnitzer B (2006) ALK-positive anaplastic large cell lymphoma with primary bone involvement in children. Am J Clin Pathol 125:57–63PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Bartl R, Frisch B, Burkhardt R, Jäger K, Pappenberger R, Hoffmann-Fezer G (1984) Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol 37:233–254PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Bartl R, Frisch B, Hill W, Burkhardt R, Sommerfeld W, Sund M (1983) Bone marrow histology in hairy cell leukemia. Identification of subtypes and their prognostic significance. Am J Clin Pathol 79:531–545PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, Thieblemont C, Ffrench M, Magaud JP, Salles G, Coiffer B (2005) Clinicopathologic features of Waldenstrom’s macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma 5:220–224PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Bleckmann K, Schrappe M (2016) Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence. Br J Haematol 172:855–869PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Borowitz MJ, Chan JKC (2008) B lymphoblastic leukemia/lymphoma not otherwise specified. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  14. 14.
    Borowitz MJ, Chan JKC (2008) B lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 171–177Google Scholar
  15. 15.
    Borowitz MJ, Chan JKC (2008) T lymphoblastic leukemia/lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 176–178Google Scholar
  16. 16.
    Boveri E, Arcaini L, Merli M, Passamonti F, Rizzi S, Vanelli L, Rumi E, Rattotti S, Lucioni M, Picone C, Castello A, Pascutto C, Magrini U, Lazzarino M, Paulli M (2009) Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Ann Oncol 20:129–136PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Brunning RD (2003) Classification of acute leukemias. Semin Diagn Pathol 20:142–153PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Buhr T, Länger F, Schlué J, Wasielewski VR, Kreipe H (2002) Histopathologie leukämischer Non-Hodgkin-Lymphome im Knochenmark. Pathologe 23:438–447PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Buhr T, Länger F, Schlué J, von Wasielewski R, Lehmann U, Braumann D, Kreipe H (2002) Reliability of lymphoma classification in bone marrow trephines. Br J Haematol 118:470–476PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Burks EJ, Loughran TP Jr (2006) Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 20:245–266PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Campo E, Catovsky D, Montserrat E, Müller-Hermelink HK, Harris NL, Stein H (2008) B-cell prolymphocytic leukaemia. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  22. 22.
    Catovsky D, Matutes E (1999) Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol 36:148–154PubMedPubMedCentralGoogle Scholar
  23. 23.
    Catovsky D, Müller-Hermelink K, Ralfkiaer E (2008) T-prolymphocytic leukemia. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  24. 24.
    Catovsky D, O’Brien M, Melo JV, Wardle J, Brozovic M (1984) Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia. Semin Oncol 11:362–369PubMedPubMedCentralGoogle Scholar
  25. 25.
    Chan WC, Foucar K, Morice WG, Catovsky D (2008) T-cell large granular lymphocytic leukemia. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  26. 26.
    Chan WC, Jaffe ES, Ralfkiaer E, Ko YH (2008) Aggressive NK-cell leukemia. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  27. 27.
    Chigrinova E, Rinaldi A, Kwee I, Rossi D, Rancoita PM, Strefford JC, Oscier D, Stamatopoulos K, Papadaki T, Berger F, Young KH, Murray F, Rosenquist R, Greiner TC, Chan WC, Orlandi EM, Lucioni M, Marasca R, Inghirami G, Ladetto M, Forconi F, Cogliatti S, Votavova H, Swerdlow SH, Stilgenbauer S, Piris MA, Matolcsy A, Spagnolo D, Nikitin E, Zamo A, Gattei V, Bhagat G, Ott G, Zucca E, Gaidano G, Bertoni F (2013) Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood 122:2673–2682PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352:804–815PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Chisholm KM, Ohgami RS, Tan B, Hasserjian RP, Weinberg OK (2017) Primary lymphoma of bone in the pediatric and young adult population. Hum Pathol 60:1–10PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Chng WJ, Schop RF, Price-Troska T, Ghobrial I, Kay N, Jelinek DF, Gertz MA, Dispenzieri A, Lacy M, Kyle RA, Greipp PR, Tschumper RC, Fonseca R, Bergsagel PL (2006) Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 108:2755–2763PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Cho YU, Chi HS, Park CJ, Jang S, Seo EJ, Huh J (2009) Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement. Am J Clin Pathol 131:640–646PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Chuang SS, Liao YL, Liou CP, Wiggins ML, Ye H, Du MQ, Isaacson PG, Chang CC (2010) Chronic lymphocytic leukemia with paraimmunoblastic transformation – with comparative genomic hybridization and review of the literature. Pathol Res Pract 206:276–281PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Chung R, Lai R, Wei P, Lee J, Hanson J, Belch AR, Turner AR, Reiman T (2007) Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood 110:1278–1282PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Cortelazzo S, Ponzoni M, Ferreri AJ, Dreyling M (2012) Mantle cell lymphoma. Crit Rev Oncol Hematol 82:78–101PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zucchetto A, Marini R, Niscola P, Consalvo MA, Mazzone C, Ottaviani L, Panetta P, Bruno A, Bomben R, Suppo G, Degan M, Gattei V, de Fabritiis P, Cantonetti M, Lo CF, Del Principe D, Amadori S (2006) Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 108:853–861PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Delsol G, Falini B, Müller-Hermelink HK, Campo E, Jaffe ES, Gascoyne RD, Stein H, Kinney MC (2008) Anaplastic large cell lymphoma (ALCL), ALK-positive. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO Classification of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, S 68–73Google Scholar
  37. 37.
    Demircay E, Hornicek FJ Jr, Mankin HJ, Degroot H 3rd (2013) Malignant lymphoma of bone: a review of 119 patients. Clin Orthop Relat Res 471:2684–2690PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Dogan A, Gaulard P, Jaffe ES, Ralfkiaer E, Müller-Hermelink HK (2008) Angioimmunoblastic T-cell lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO Classification of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, S 68–73Google Scholar
  39. 39.
    Dogan A, Morice WG (2004) Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematol 127:140–154PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910–1916PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Estalilla OC, Koo CH, Brynes RK, Medeiros LJ (1999) Intravascular large B-cell lymphoma. A report of five cases initially diagnosed by bone marrow biopsy. Am J Clin Pathol 112:248–255PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Faderl S, O’Brien S, Pui CH, Stock W, Wetzler M, Hoelzer D, Kantarjian HM (2010) Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 116:1165–1176PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R, Foa R, Pulsoni A, Dalla Favera R, Pileri S (2004) Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 363:1869–1870PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Ferreira OC Jr, Planelles V, Rosenblatt JD (1997) Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev 11:91–104PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, Zucca E, Rossi G, López-Guillermo A, Pavlovsky MA, Geerts ML, Candoni A, Lestani M, Asioli S, Milani M, Piris MA, Pileri S, Facchetti F, Cavalli F, Ponzoni M, International Extranodal Lymphoma Study Group (IELSG) (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127:173–183PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Foucar K (2007) Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome. Am J Clin Pathol 127:496–510PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Foucar K, Falini B, Catovsky D, Stein H (2008) Hairy cell leukaemia. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  48. 48.
    Gaulard P, Jaffe ES, Krenacs L, Macon WR (2008) Hepatosplenic T-cell lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  49. 49.
    Geisler CH, Hou-Jensen K, Jensen OM, Tinggaard-Pedersen N, Hansen MM, Hansen NE, Holm M, Christensen BE, Drivsholm A, Nielsen JB, Thorling K, Andersen E, Larsen JK, Anderson PK (1996) The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol 57:292–300PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    George CD, Wilson AG, Philpott NJ, Bevan DH (1994) The radiological features of adult T-cell leukaemia/lymphoma. Clin Radiol 49:83–88PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Geyer JT, Subramaniyam S, Jiang Y, Elemento O, Ferry JA, de Leval L, Nakashima MO, Liu YC, Martin P, Mathew S, Orazi A, Tam W (2015) Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. Hum Pathol 46:260–271PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Go RS, Lust JA, Phyliky RL (2003) Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Semin Hematol 40:196–200PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B (2017) Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood 129:553–560PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Grogg KL, Morice WG, Macon WR (2007) Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma. Br J Haematol 137:416–422PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Harris NL, Swerlow SH, Jaffe ES, Ott G, Nathwani BN, de Jong D, Yoshino T, Spagnolo D (2008) Follicular lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  56. 56.
    Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, McCastlain K, Becksfort J, Ma J, Wu G, Patel SN, Heatley SL, Phillips LA, Song G, Easton J, Parker M, Chen X, Rusch M, Boggs K, Vadodaria B, Hedlund E, Drenberg C, Baker S, Pei D, Cheng C, Huether R, Lu C, Fulton RS, Fulton LL, Tabib Y, Dooling DJ, Ochoa K, Minden M, Lewis ID, To LB, Marlton P, Roberts AW, Raca G, Stock W, Neale G, Drexler HG, Dickins RA, Ellison DW, Shurtleff SA, Pui CH, Ribeiro RC, Devidas M, Carroll AJ, Heerema NA, Wood B, Borowitz MJ, Gastier-Foster JM, Raimondi SC, Mardis ER, Wilson RK, Downing JR, Hunger SP, Loh ML, Mullighan CG (2013) The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 45:242–252PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Hounieu H, Chittal SM, al Saati T, de Mascarel A, Sabattini E, Pileri S, Falini B, Ralfkiaer E, Le Tourneau A, Selves J et al (1992) Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44. Am J Clin Pathol 98:26–33PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Howell SJ, Grey M, Chang J, Morgenstern GR, Cowan RA, Deakin DP, Radford JA (2002) The value of bone marrow examination in the staging of Hodgkin’s lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 119:408–411PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Iancu D, Hao S, Lin P, Anderson SK, Jorgensen JL, McLaughlin P, Medeiros LJ (2007) Follicular lymphoma in staging bone marrow specimens: correlation of histologic findings with the results of flow cytometry immunophenotypic analysis. Arch Pathol Lab Med 131:282–287PubMedPubMedCentralGoogle Scholar
  60. 60.
    Inamdar KV, Medeiros LJ, Jorgensen JL, Amin HM, Schlette EJ (2008) Bone marrow involvement by marginal zone B-cell lymphomas of different types. Am J Clin Pathol 129:714–722PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Isaacson PG, Chott A, Nakamura S, Campo E, Müller-Hermelink HK, Harris NL, Swerdlow SH (2008) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  62. 62.
    Isaacson PG, Piris MA, Berger F, Swerdlow SH, Thieblemont C, Pittaluga S, Harris NL (2008) Splenic marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  63. 63.
    Jawad MU, Schneiderbauer MM, Min ES, Cheung MC, Koniaris LG, Scully SP (2010) Primary lymphoma of bone in adult patients. Cancer 116:871–879PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Jimenez C, Sebastian E, Chillon MC, Giraldo P, Mariano HJ, Escalante F, Gonzalez-Lopez TJ, Aguilera C, de Coca AG, Murillo I, Alcoceba M, Balanzategui A, Sarasquete ME, Corral R, Marin LA, Paiva B, Ocio EM, Gutierrez NC, Gonzalez M, San Miguel JF, Garcia-Sanz R (2013) MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom’s macroglobulinemia. Leukemia 27:1722–1728PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Kajiura D, Yamashita Y, Mori N (2007) Diffuse large B-cell lymphoma initially manifesting in the bone marrow. Am J Clin Pathol 127:762–769PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Kanzler H, Küppers R, Helmes S, Wacker HH, Chott A, Hansmann ML, Rajewsky K (2000) Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin’s disease. Blood 95:1023–1031PubMedPubMedCentralGoogle Scholar
  67. 67.
    Kent SA, Variakojis D, Peterson LC (2002) Comparative study of marginal zone lymphoma involving bone marrow. Am J Clin Pathol 117:698–708PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Khokhar FA, Payne WD, Talwalkar SS, Jorgensen JL, Bueso-Ramos CE, Medeiros LJ, Vega F (2010) Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study. Hum Pathol 41:79–87PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Khoury JD, Jones D, Yared MA, Manning JT Jr, Abruzzo LV, Hagemeister FB, Medeiros LJ (2004) Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 28:489–495PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Kim YS, Ford RJ Jr, Faber JA, Bell RH, Elenitoba-Johnson KS, Medeiros LJ (2000) B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma involving bone marrow with an interfollicular pattern. Am J Clin Pathol 114:41–46PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Kitsoulis P, Vlychou M, Papoudou-Bai A, Karatzias G, Charchanti A, Agnantis NJ, Bai M (2006) Primary lymphomas of bone. Anticancer Res 26:325–337PubMedPubMedCentralGoogle Scholar
  72. 72.
    Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmaki H, Andersson EI, Lagstrom S, Clemente MJ, Olson T, Jalkanen SE, Majumder MM, Almusa H, Edgren H, Lepisto M, Mattila P, Guinta K, Koistinen P, Kuittinen T, Penttinen K, Parsons A, Knowles J, Saarela J, Wennerberg K, Kallioniemi O, Porkka K et al (2012) Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 366:1905–1913PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Kremer M, Spitzer M, Mandl-Weber S, Stecker K, Schmidt B, Höfler H, Quintanilla-Martínez L, Fend F (2003) Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders. Lab Invest 83:107–114PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Kumar KR, Chen W, Koduru PR, Luu HS (2015) Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature. Am J Clin Pathol 143:738–748PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Lampert I, Catovsky D, Marsh GW, Child JA, Galton DA (1980) The histopathology of prolymphocytic leukaemia with particular reference to the spleen: a comparison with chronic lymphocytic leukaemia. Histopathology 4:3–19PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Lennert K (1980) Histopathologie der Non-Hodgkin-Lymphome nach der Kiel Klassifikation. Springer, HeidelbergGoogle Scholar
  77. 77.
    Leoncini L, Raphael M, Stein H, Jaffe ES, Kluin PM (2008) Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  78. 78.
    Li Y, Wang XB, Tian XY, Li B, Li Z (2012) Unusual primary osseous Hodgkin lymphoma in rib with associated soft tissue mass: a case report and review of literature. Diagn Pathol 7:64PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Lundell R, Hartung L, Hill S, Perkins SL, Bahler DW (2005) T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 124:937–946PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Machatschek JN, Westerman D, Prince HM, Seymour JF (2003) A case of clinical indolent natural killer cell lineage large granular lymphocytic leukemia in a patient with rheumatoid arthritis. Leuk Lymphoma 44:1223–1227PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Matikas A, Briasoulis A, Tzannou I, Oikonomopoulou D, Bakiri M, Karmiris T, Harhalakis N (2013) Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center. Acta Haematol 130:291–296PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, Felman P, Franco V, Iannitto E, Mollejo M, Papadaki T, Remstein ED, Salar A, Solé F, Stamatopoulos K, Thieblemont C, Traverse-Glehen A, Wotherspoon A, Coiffier B, Piris MA (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22:487–495PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Matutes E, Parry-Jones N, Brito-Babapulle V, Wotherspoon A, Morilla R, Atkinson S, Elnenaei MO, Jain P, Giustolisi GM, A’Hern RP, Catovsky D (2004) The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients. Leuk Lymphoma 45:2007–2015PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Matutes E (2017) Large granular lymphocytic leukemia. Current diagnostic and therapeutic approaches and novel treatment options. Expert Rev Hematol 10:251–258PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, Hallek M, Wendtner CM (2006) Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107:742–751PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Messina C, Christie D, Zucca E, Gospodarowicz M, Ferreri AJ (2015) Primary and secondary bone lymphomas. Cancer Treat Rev 41:235–246PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Morice WG, Kurtin PJ, Tefferi A, Hanson CA (2002) Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 99:268–274PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Morice WG, Rodriguez FJ, Hoyer JD, Kurtin PJ (2005) Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases. Mod Pathol 18:495–502PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Müller-Hermelink HK, Montserrat E, Catovsky D, Campo E, Harris NL, Stein H (2008) Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO Classification of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, S 168–170Google Scholar
  90. 90.
    Munker R, Hasenclever D, Brosteanu O, Hiller E, Diehl V (1995) Bone marrow involvement in Hodgkin’s disease: an analysis of 135 consecutive cases. German Hodgkin’s Lymphoma Study Group. J Clin Oncol 13:403–409PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Mussolin L, Pillon M, d’Amore ES, Santoro N, Lombardi A, Fagioli F, Zanesco L, Rosolen A (2005) Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma. Leukemia 19:1643–1647PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Nicot C (2005) Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol 78:232–239PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Nieto LH, Lampert IA, Catovsky D (1989) Bone marrow histological patterns in B-cell and T-cell prolymphocytic leukemia. Hematol Pathol 3:79–84PubMedPubMedCentralGoogle Scholar
  94. 94.
    Ohgami RS, Arber DA, Zehnder JL, Natkunam Y, Warnke RA (2013) Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma. Adv Anat Pathol 20:137–140PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Ohshima K, Jaffe ES, Kikuchhi M (2008) Adult T-cell leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  96. 96.
    O’Malley DP (2007) T-cell large granular leukemia and related proliferations. Am J Clin Pathol 127:850–859PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Oscier D, Owen R, Johnson S (2005) Splenic marginal zone lymphoma. Blood Rev 19:39–51PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Osuji N, Beiske K, Randen U, Matutes E, Tjonnfjord G, Catovsky D, Wotherspoon A (2007) Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. Histopathology 50:547–554PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA (2003) Clinicopathological definition of Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s Macroglobulinemia. Semin Oncol 30:110–115PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Perea G, Altés A, Bellido M, Aventín A, Bordes R, Ayats R, Remacha AF, Espinosa I, Briones J, Sierra J, Nomdedéu JF (2004) Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL). Histopathology 45:268–274PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Piris M, Foucar K, Mollejo M, Campo E, Catovsky D, Falini B (2008) Splenic B-cell lymphoma/leukaemia unclassifiable. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  102. 102.
    Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Viganò MG, Guidoboni M, Dolcetti R, McKenna RW, Facchetti F (2002) Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 15:1273–1278PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Ralfkiaer E, Cerroni L, Sander CA, Smoller BR, Willemze R (2008) Mycosis fungoides. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  104. 104.
    Ralfkiaer E, Willemze R, Whittaker SJ (2008) Sézary syndrome. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–173Google Scholar
  105. 105.
    Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD, Connors JM (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 18:129–135PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Rawstron AC, Bennett FL, O’Connor SJ, Kwok M, Fenton JA, Plummer M, de Tute R, Owen RG, Richards SJ, Jack AS, Hillmen P (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359:575–583PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, McCastlain K, Ding L, Lu C, Song G, Ma J, Becksfort J, Rusch M, Chen SC, Easton J, Cheng J, Boggs K, Santiago-Morales N, Iacobucci I, Fulton RS, Wen J, Valentine M, Cheng C, Paugh SW, Devidas M, Chen IM, Reshmi S, Smith A, Hedlund E, Gupta P, Nagahawatte P, Wu G, Chen X, Yergeau D, Vadodaria B, Mulder H, Winick NJ, Larsen EC, Carroll WL, Heerema NA, Carroll AJ, Grayson G, Tasian SK, Moore AS, Keller F, Frei-Jones M, Whitlock JA, Raetz EA, White DL, Hughes TP, Guidry Auvil JM, Smith MA, Marcucci G, Bloomfield CD, Mrózek K, Kohlschmidt J, Stock W, Kornblau SM, Konopleva M, Paietta E, Pui CH, Jeha S, Relling MV, Evans WE, Gerhard DS, Gastier-Foster JM, Mardis E, Wilson RK, Loh ML, Downing JR, Hunger SP, Willman CL, Zhang J, Mullighan CG (2014) Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371:1005–1015PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D (2004) B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol 125:330–336PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Schade U, Bock O, Vornhusen S, Jäger A, Büsche G, Lehmann U, Kreipe H (2006) Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70). Hum Pathol 37:1153–1161PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Schenka AA, Gascoyne RD, Duchayne E, Delsol G, Brousset P (2003) Prominent intrasinusoidal infiltration of the bone marrow by mantle cell lymphoma. Hum Pathol 34:789–791PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Schmidt B, Kremer M, Götze K, John K, Peschel C, Höfler H, Fend F (2006) Bone marrow involvement in follicular lymphoma: comparison of histology and flow cytometry as staging procedures. Leuk Lymphoma 47:1857–1862PubMedCrossRefPubMedCentralGoogle Scholar
  112. 112.
    Schnittger S, Bacher U, Haferlach T, Wendland N, Ulke M, Dicker F, Grossmann V, Haferlach C, Kern W (2012) Development and validation of a realtime quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia. Blood 119:3151–3154PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Sibaud V, Beylot-Barry M, Thiébaut R, Parrens M, Vergier B, Delaunay M, Beylot C, Chêne G, Ferrer J, de Mascarel A, Dubus P, Merlio JP (2003) Bone marrow histopathologic and molecular staging in epidermotropic T-cell lymphomas. Am J Clin Pathol 119:414–423PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Simpson CD, Gao J, Fernandez CV, Yhap M, Price VE, Berman JN (2008) Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective. Br J Haematol 141:820–826PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Skinnider BF, Connors JM, Gascoyne RD (1997) Bone marrow involvement in T-cell-rich B-cell lymphoma. Am J Clin Pathol 108:570–578PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Stein H, Warnke RA, Chan WC, Jaffe ES, Chan JKC, Gatter KC, Campo E (2008) Diffuse large B-cell lymphoma not otherwise specified. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  117. 117.
    Swerdlow SH, Berger F, Pileri SA, Harris NL, Jaffe ES, Stein H (2008) Lymphoplasmocytic lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  118. 118.
    Swerdlow SH, Campo E, Seto M, Müller-Hermelink HK (2008) Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 168–170Google Scholar
  119. 119.
    Swerdlow SH, Webber SA, Chadburn A, Ferry JA (2008) Posttransplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  120. 120.
    Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F, Coiffier B (2003) Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 4:95–103PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Thomson JJ, Walt JV, Ireland R (2007) Bone marrow trephine biopsy appearances of the intravascular subtype of diffuse large B-cell lymphoma. Br J Haematol 136:683PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Torlakovic E, Torlakovic G, Brunning RD (2002) Follicular pattern of bone marrow involvement by follicular lymphoma. Am J Clin Pathol 118:780–786PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR (2012) MYD88 L265P somatic mutation in Waldenstrom’s macroglobulinemia. N Engl J Med 367:826–833PubMedCrossRefPubMedCentralGoogle Scholar
  124. 124.
    Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, Pileri SA (2009) Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 6:707–717PubMedPubMedCentralCrossRefGoogle Scholar
  125. 125.
    Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R, Abruzzo LV (2001) Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116:410–419PubMedPubMedCentralCrossRefGoogle Scholar
  126. 126.
    Villamor N, Morice WG, Chan WC, Foucar K (2008) Chronic lymphoproliferative disorders of NK cells. In: Swerdlow SH, Campo E, Harris LN, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 68–73Google Scholar
  127. 127.
    Viswanatha D, Foucar K (2003) Hodgkin and non-Hodgkin lymphoma involving bone marrow. Semin Diagn Pathol 20:196–210PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Vitolo U, Ferreri AJ, Montoto S (2008) Lymphoplasmacytic lymphoma-Waldenstrom’s macroglobulinemia. Crit Rev Oncol Hematol 67:172–185PubMedPubMedCentralCrossRefGoogle Scholar
  129. 129.
    Vonderheid EC (2006) On the diagnosis of erythrodermic cutaneous T-cell lymphoma. J Cutan Pathol 33(Suppl 1):27–42PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Weinberg JB, Volkheimer AD, Chen Y, Beasley BE, Jiang N, Lanasa MC, Friedman D, Vaccaro G, Rehder CW, Decastro CM, Rizzieri DA, Diehl LF, Gockerman JP, Moore JO, Goodman BK, Levesque MC (2007) Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. Am J Hematol 82:1063–1070 (Erratum: Am J Hematol 2008; 83:90)PubMedPubMedCentralCrossRefGoogle Scholar
  131. 131.
    You MJ, Medeiros LJ, Hsi ED (2015) T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol 144:411–422PubMedCrossRefPubMedCentralGoogle Scholar
  132. 132.
    Zanotti R, Ambrosetti A, Lestani M, Ghia P, Pattaro C, Remo A, Zanetti F, Stella S, Perbellini O, Prato G, Guida G, Caligaris-Cappio F, Menestrina F, Pizzolo G, Chilosi M (2007) ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Leukemia 21:102–109PubMedCrossRefPubMedCentralGoogle Scholar
  133. 133.
    Zenz T, Kröber A, Scherer K, Häbe S, Bühler A, Benner A, Denzel T, Winkler D, Edelmann J, Schwänen C, Döhner H, Stilgenbauer S (2008) Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood 112:3322–3329PubMedCrossRefPubMedCentralGoogle Scholar
  134. 134.
    Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore KP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenauer JC, Evans WE, Pui CH, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR, Mullighan CG (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481:157–163PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Institut für PathologieMedizinische Hochschule Hannover (MHH)HannoverDeutschland

Personalised recommendations